Test your knowledge on changing approaches to managing patients with asthma outlined in the 2026 GINA asthma update.

The FDA authorized marketing of 20 ZYN products as a lower risk than cigarettes, which drew immediate criticism from anti-cancer advocates.

One of the biggest themes for ATS this year is the dramatically growing role of AI in all aspects of pulmonary disease, ...

HHS terminates COVID-19 Emergency Use Authorizations for drugs, biologics, and devices, establishing transition timelines toward traditional FDA pathways.

Stool-based testing has poor sensitivity and low negative predictive value for colorectal cancer screening in patients with cystic fibrosis.

Patients with cystic fibrosis often reduce or discontinue respiratory cotherapies after starting CFTR modulators without affecting clinical status.

Divarasib demonstrated superior progression-free and overall survival compared with sotorasib or adagrasib in previously treated KRAS G12C NSCLC.

Even after the introduction of ETI for cystic fibrosis, habit continues to have a key role in adherence to inhaled medicines in patients with CF.

For adults with prediabetes, lifestyle intervention is associated with a lower burden of multimorbidity over long-term follow-up.

Anxiety and depression are common in patients with idiopathic pulmonary fibrosis and are significantly affected by the diagnostic criteria used.

Individuals who survive hematologic cancers are at high risk for subsequently developing cardiovascular disease.

Sugammadex lowers the risk for postoperative pulmonary complications vs neostigmine after major abdominal or thoracic surgery in older adults.